Sacubitril/valsartan for the treatment of non-obstructive hypertrophic cardiomyopathy: An open label randomized controlled trial (SILICOFCM)
- SILICOFCM Investigators
- University of Novi Sad
- Institute of Cardiovascular Diseases of Vojvodina
- University of Belgrade
- Newcastle University
- Coventry University
- University of Regensburg
- Azienda Ospedaliera Careggi
- Newcastle Upon Tyne Hospitals NHS Foundation Trust
- BioIRC
- University of Kragujevac
Research output: Contribution to journal › Article › peer-review
19
Link opens in a new tab
Scopus
citations